Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.75 |
| ▸ | CNR1 | P21554 | 4/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | THPO | P40225 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | GMNN | O75496 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | APEX1 | P27695 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11165640 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11160652 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11156383 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11170587 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11167646 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11166256 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11171046 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11160655 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL15478743 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11156389 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20210308095-A1 | Cannabinoid-Containing Composition | JOYN BOTANICALS LTD. (CA) | 2021-10-07 | — | — | US | claimed |
| EP-2704793-B1 | REGULATION OF AMYLOID BETA MOLECULAR COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE | UNIV RAMOT (IL) | 2019-07-17 | — | — | EP | claimed |
| US-9192670-B2 | Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-11-24 | — | — | US | claimed |
| US-20250177354-A1 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | MINDSTATE DESIGN LABS INC (US) | 2025-06-05 | — | — | US | disclosed |
| CN-119497589-A | Therapeutic combinations, compositions and methods for designing and producing conditions that promote mental well-being | 心境设计实验室股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-20210308095-A1 | Cannabinoid-Containing Composition | JOYN BOTANICALS LTD. (CA) | 2021-10-07 | — | — | US | disclosed |
| EP-2698383-B1 | Detection of synthetic Cannabinoids | RANDOX LABORATORIES LTD (GB) | 2020-11-25 | — | — | EP | disclosed |
| WO-2020232350-A1 | ASSAYS FOR SYNTHETIC CANNABINOIDS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-2704793-B1 | REGULATION OF AMYLOID BETA MOLECULAR COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE | UNIV RAMOT (IL) | 2019-07-17 | — | — | EP | disclosed |
| US-9435817-B2 | Detection of synthetic cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2016-09-06 | — | — | US | disclosed |
| US-9192670-B2 | Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-11-24 | — | — | US | disclosed |
| US-20150152348-A1 | SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS | SHARPS COMPLIANCE, INC. OF TEXAS | 2015-06-04 | — | — | US | disclosed |
| EP-2698383-A1 | Detection of synthetic Cannabinoids | Randox Laboratories Ltd. (GB) | 2014-02-19 | — | — | EP | disclosed |
| US-20130065323-A1 | Detection of Synthetic Cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2013-03-14 | — | — | US | disclosed |
| US-4391827-A | 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor | PFIZER INC. (US) | 1983-07-05 | — | — | US | disclosed |
| US-4306097-A | 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents | PFIZER INC. (US) | 1981-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177354-A1 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | CNR2, CNR1, HTR6 | CNR2 1/4885CNR1 2/4885TSHR 532/4885 |
| US-20130065323-A1 | Detection of Synthetic Cannabinoids | CNR2, CNR1, MAG | CNR2 1/4885CNR1 2/4885TSHR 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.